Verona Pharma plc (VRNA)
Oct 7, 2025 - VRNA was delisted (reason: acquired by MRK)
106.91
+0.12 (0.11%)
Inactive · Last trade price on Oct 6, 2025
Verona Pharma Revenue
Verona Pharma had revenue of $103.14M in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to $221.67M. In the year 2024, Verona Pharma had annual revenue of $42.28M.
Revenue (ttm)
$221.67M
Revenue Growth
n/a
P/S Ratio
40.39
Revenue / Employee
$1,060,636
Employees
209
Market Cap
9.21B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 42.28M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 458.00K | -39.54M | -98.86% |
| Dec 31, 2021 | 40.00M | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionVRNA News
- 23 days ago - Acquisition of Verona by MSD Approved by the High Court of Justice of England and Wales - GlobeNewsWire
- 5 weeks ago - Shareholders of Verona Pharma Approve Proposed Acquisition by Merck - GlobeNewsWire
- 6 weeks ago - Verona Pharma to Present Additional Analyses of the Phase 3 ENHANCE Studies in COPD at ERS International Congress 2025 - GlobeNewsWire
- 3 months ago - VERONA PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Verona Pharma plc - VRNA - Business Wire
- 4 months ago - Major deals involving U.S. drugmakers and biotechs over the past decade - Reuters
- 4 months ago - Two big reasons why buying Verona was crucial for Merck - Invezz
- 4 months ago - Merck has struck a roughly $10 billion deal to buy Verona Pharma - WSJ
- 4 months ago - Verona Pharma shares jump with Merck set to acquire company in $10 billion deal - Invezz